instruction stringlengths 34 186 | input stringlengths 2.02k 93.8k | output stringlengths 2 418 | meta_questiontype stringclasses 6
values | meta_inputlicense stringclasses 6
values | meta_pmid stringlengths 8 8 | meta_safetyreportid int64 9.51M 21M | meta_articlepubdate stringlengths 4 10 |
|---|---|---|---|---|---|---|---|
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | Capecitabine-Induced Terminal Ileitis: Case Report and Literature Review.
Capecitabine is a well-established agent for adjuvant chemotherapy in breast and colorectal cancers. However, one of the limiting adverse events of this therapy is severe diarrhea, which is reported with increasing frequency as of late. Capecitab... | CAPECITABINE, LOPERAMIDE HYDROCHLORIDE, OCTREOTIDE | DrugsGivenReaction | CC BY | 34055501 | 19,483,180 | 2021-04-21 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Terminal ileitis'. | Capecitabine-Induced Terminal Ileitis: Case Report and Literature Review.
Capecitabine is a well-established agent for adjuvant chemotherapy in breast and colorectal cancers. However, one of the limiting adverse events of this therapy is severe diarrhea, which is reported with increasing frequency as of late. Capecitab... | CAPECITABINE, INSULIN NOS | DrugsGivenReaction | CC BY | 34055501 | 19,429,128 | 2021-04-21 |
What was the outcome of reaction 'Drug ineffective'? | Capecitabine-Induced Terminal Ileitis: Case Report and Literature Review.
Capecitabine is a well-established agent for adjuvant chemotherapy in breast and colorectal cancers. However, one of the limiting adverse events of this therapy is severe diarrhea, which is reported with increasing frequency as of late. Capecitab... | Recovered | ReactionOutcome | CC BY | 34055501 | 19,483,180 | 2021-04-21 |
What was the outcome of reaction 'Terminal ileitis'? | Capecitabine-Induced Terminal Ileitis: Case Report and Literature Review.
Capecitabine is a well-established agent for adjuvant chemotherapy in breast and colorectal cancers. However, one of the limiting adverse events of this therapy is severe diarrhea, which is reported with increasing frequency as of late. Capecitab... | Recovering | ReactionOutcome | CC BY | 34055501 | 19,429,128 | 2021-04-21 |
What was the administration route of drug 'OXYBUTYNIN CHLORIDE'? | Oxybutynin-Induced Hyperthermia in a Patient With Parkinson's Disease.
Impaired thermoregulation and heat intolerance may be intrinsic to autonomic dysfunction in Parkinson's disease due to disturbances in perspiration regulation. Thermoregulatory impairment leading to hyperthermia/heatstroke can be accentuated with th... | Oral | DrugAdministrationRoute | CC BY | 34055543 | 19,438,268 | 2021-04-26 |
What was the administration route of drug 'OXYBUTYNIN'? | Oxybutynin-Induced Hyperthermia in a Patient With Parkinson's Disease.
Impaired thermoregulation and heat intolerance may be intrinsic to autonomic dysfunction in Parkinson's disease due to disturbances in perspiration regulation. Thermoregulatory impairment leading to hyperthermia/heatstroke can be accentuated with th... | Oral | DrugAdministrationRoute | CC BY | 34055543 | 20,255,331 | 2021-04-26 |
What was the dosage of drug 'OXYBUTYNIN CHLORIDE'? | Oxybutynin-Induced Hyperthermia in a Patient With Parkinson's Disease.
Impaired thermoregulation and heat intolerance may be intrinsic to autonomic dysfunction in Parkinson's disease due to disturbances in perspiration regulation. Thermoregulatory impairment leading to hyperthermia/heatstroke can be accentuated with th... | 5 mg (milligrams). | DrugDosage | CC BY | 34055543 | 19,438,268 | 2021-04-26 |
What was the outcome of reaction 'Heat stroke'? | Oxybutynin-Induced Hyperthermia in a Patient With Parkinson's Disease.
Impaired thermoregulation and heat intolerance may be intrinsic to autonomic dysfunction in Parkinson's disease due to disturbances in perspiration regulation. Thermoregulatory impairment leading to hyperthermia/heatstroke can be accentuated with th... | Recovered | ReactionOutcome | CC BY | 34055543 | 19,438,268 | 2021-04-26 |
What was the outcome of reaction 'Hyperthermia'? | Oxybutynin-Induced Hyperthermia in a Patient With Parkinson's Disease.
Impaired thermoregulation and heat intolerance may be intrinsic to autonomic dysfunction in Parkinson's disease due to disturbances in perspiration regulation. Thermoregulatory impairment leading to hyperthermia/heatstroke can be accentuated with th... | Recovered | ReactionOutcome | CC BY | 34055543 | 19,438,268 | 2021-04-26 |
What was the outcome of reaction 'Medication error'? | Oxybutynin-Induced Hyperthermia in a Patient With Parkinson's Disease.
Impaired thermoregulation and heat intolerance may be intrinsic to autonomic dysfunction in Parkinson's disease due to disturbances in perspiration regulation. Thermoregulatory impairment leading to hyperthermia/heatstroke can be accentuated with th... | Not recovered | ReactionOutcome | CC BY | 34055543 | 19,438,268 | 2021-04-26 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Conjunctival hyperaemia'. | Clinical Aspects of Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis With Severe Ocular Complications in Taiwan.
Purpose: Over the last decade, there has been tremendous progress in the treatment of Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN). To understand whether this has resulted in better... | IBUPROFEN | DrugsGivenReaction | CC BY | 34055837 | 19,922,595 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Conjunctivitis'. | Clinical Aspects of Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis With Severe Ocular Complications in Taiwan.
Purpose: Over the last decade, there has been tremendous progress in the treatment of Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN). To understand whether this has resulted in better... | IBUPROFEN | DrugsGivenReaction | CC BY | 34055837 | 19,922,595 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Corneal epithelium defect'. | Clinical Aspects of Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis With Severe Ocular Complications in Taiwan.
Purpose: Over the last decade, there has been tremendous progress in the treatment of Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN). To understand whether this has resulted in better... | IBUPROFEN | DrugsGivenReaction | CC BY | 34055837 | 19,922,595 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Eye disorder'. | Clinical Aspects of Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis With Severe Ocular Complications in Taiwan.
Purpose: Over the last decade, there has been tremendous progress in the treatment of Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN). To understand whether this has resulted in better... | IBUPROFEN | DrugsGivenReaction | CC BY | 34055837 | 19,922,595 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Eyelid injury'. | Clinical Aspects of Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis With Severe Ocular Complications in Taiwan.
Purpose: Over the last decade, there has been tremendous progress in the treatment of Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN). To understand whether this has resulted in better... | IBUPROFEN | DrugsGivenReaction | CC BY | 34055837 | 19,922,595 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Stevens-Johnson syndrome'. | Clinical Aspects of Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis With Severe Ocular Complications in Taiwan.
Purpose: Over the last decade, there has been tremendous progress in the treatment of Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN). To understand whether this has resulted in better... | IBUPROFEN | DrugsGivenReaction | CC BY | 34055837 | 19,922,595 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Toxic epidermal necrolysis'. | Clinical Aspects of Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis With Severe Ocular Complications in Taiwan.
Purpose: Over the last decade, there has been tremendous progress in the treatment of Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN). To understand whether this has resulted in better... | IBUPROFEN | DrugsGivenReaction | CC BY | 34055837 | 19,922,595 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Acinetobacter infection'. | Nicolau Syndrome: An Unforeseen Yet Evadable Consequence of Intramuscular Injection.
An intramuscular (IM) injection is one of the common routes for administering drugs, commonly analgesics and vaccines. Nicolau syndrome refers to the rapid-onset painful, extensive cutaneous discoloration progressing to necrosis and ul... | DICLOFENAC | DrugsGivenReaction | CC BY | 34056105 | 19,429,833 | 2021-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Blister'. | Nicolau Syndrome: An Unforeseen Yet Evadable Consequence of Intramuscular Injection.
An intramuscular (IM) injection is one of the common routes for administering drugs, commonly analgesics and vaccines. Nicolau syndrome refers to the rapid-onset painful, extensive cutaneous discoloration progressing to necrosis and ul... | DICLOFENAC | DrugsGivenReaction | CC BY | 34056105 | 19,429,833 | 2021-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Embolia cutis medicamentosa'. | Nicolau Syndrome: An Unforeseen Yet Evadable Consequence of Intramuscular Injection.
An intramuscular (IM) injection is one of the common routes for administering drugs, commonly analgesics and vaccines. Nicolau syndrome refers to the rapid-onset painful, extensive cutaneous discoloration progressing to necrosis and ul... | DICLOFENAC | DrugsGivenReaction | CC BY | 34056105 | 19,426,438 | 2021-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Erythema'. | Nicolau Syndrome: An Unforeseen Yet Evadable Consequence of Intramuscular Injection.
An intramuscular (IM) injection is one of the common routes for administering drugs, commonly analgesics and vaccines. Nicolau syndrome refers to the rapid-onset painful, extensive cutaneous discoloration progressing to necrosis and ul... | DICLOFENAC | DrugsGivenReaction | CC BY | 34056105 | 19,429,833 | 2021-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Eschar'. | Nicolau Syndrome: An Unforeseen Yet Evadable Consequence of Intramuscular Injection.
An intramuscular (IM) injection is one of the common routes for administering drugs, commonly analgesics and vaccines. Nicolau syndrome refers to the rapid-onset painful, extensive cutaneous discoloration progressing to necrosis and ul... | DICLOFENAC | DrugsGivenReaction | CC BY | 34056105 | 19,429,833 | 2021-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Klebsiella infection'. | Nicolau Syndrome: An Unforeseen Yet Evadable Consequence of Intramuscular Injection.
An intramuscular (IM) injection is one of the common routes for administering drugs, commonly analgesics and vaccines. Nicolau syndrome refers to the rapid-onset painful, extensive cutaneous discoloration progressing to necrosis and ul... | DICLOFENAC | DrugsGivenReaction | CC BY | 34056105 | 19,429,833 | 2021-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Lymphocytic infiltration'. | Nicolau Syndrome: An Unforeseen Yet Evadable Consequence of Intramuscular Injection.
An intramuscular (IM) injection is one of the common routes for administering drugs, commonly analgesics and vaccines. Nicolau syndrome refers to the rapid-onset painful, extensive cutaneous discoloration progressing to necrosis and ul... | DICLOFENAC | DrugsGivenReaction | CC BY | 34056105 | 19,429,833 | 2021-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Necrosis'. | Nicolau Syndrome: An Unforeseen Yet Evadable Consequence of Intramuscular Injection.
An intramuscular (IM) injection is one of the common routes for administering drugs, commonly analgesics and vaccines. Nicolau syndrome refers to the rapid-onset painful, extensive cutaneous discoloration progressing to necrosis and ul... | DICLOFENAC | DrugsGivenReaction | CC BY | 34056105 | 19,429,833 | 2021-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Neutrophilia'. | Nicolau Syndrome: An Unforeseen Yet Evadable Consequence of Intramuscular Injection.
An intramuscular (IM) injection is one of the common routes for administering drugs, commonly analgesics and vaccines. Nicolau syndrome refers to the rapid-onset painful, extensive cutaneous discoloration progressing to necrosis and ul... | DICLOFENAC | DrugsGivenReaction | CC BY | 34056105 | 19,429,833 | 2021-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pain'. | Nicolau Syndrome: An Unforeseen Yet Evadable Consequence of Intramuscular Injection.
An intramuscular (IM) injection is one of the common routes for administering drugs, commonly analgesics and vaccines. Nicolau syndrome refers to the rapid-onset painful, extensive cutaneous discoloration progressing to necrosis and ul... | DICLOFENAC | DrugsGivenReaction | CC BY | 34056105 | 19,429,833 | 2021-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Purulent discharge'. | Nicolau Syndrome: An Unforeseen Yet Evadable Consequence of Intramuscular Injection.
An intramuscular (IM) injection is one of the common routes for administering drugs, commonly analgesics and vaccines. Nicolau syndrome refers to the rapid-onset painful, extensive cutaneous discoloration progressing to necrosis and ul... | DICLOFENAC | DrugsGivenReaction | CC BY | 34056105 | 19,429,833 | 2021-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Red blood cell sedimentation rate increased'. | Nicolau Syndrome: An Unforeseen Yet Evadable Consequence of Intramuscular Injection.
An intramuscular (IM) injection is one of the common routes for administering drugs, commonly analgesics and vaccines. Nicolau syndrome refers to the rapid-onset painful, extensive cutaneous discoloration progressing to necrosis and ul... | DICLOFENAC | DrugsGivenReaction | CC BY | 34056105 | 19,429,833 | 2021-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Skin burning sensation'. | Nicolau Syndrome: An Unforeseen Yet Evadable Consequence of Intramuscular Injection.
An intramuscular (IM) injection is one of the common routes for administering drugs, commonly analgesics and vaccines. Nicolau syndrome refers to the rapid-onset painful, extensive cutaneous discoloration progressing to necrosis and ul... | DICLOFENAC | DrugsGivenReaction | CC BY | 34056105 | 19,429,833 | 2021-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Skin discolouration'. | Nicolau Syndrome: An Unforeseen Yet Evadable Consequence of Intramuscular Injection.
An intramuscular (IM) injection is one of the common routes for administering drugs, commonly analgesics and vaccines. Nicolau syndrome refers to the rapid-onset painful, extensive cutaneous discoloration progressing to necrosis and ul... | DICLOFENAC | DrugsGivenReaction | CC BY | 34056105 | 19,429,833 | 2021-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'White blood cell count increased'. | Nicolau Syndrome: An Unforeseen Yet Evadable Consequence of Intramuscular Injection.
An intramuscular (IM) injection is one of the common routes for administering drugs, commonly analgesics and vaccines. Nicolau syndrome refers to the rapid-onset painful, extensive cutaneous discoloration progressing to necrosis and ul... | DICLOFENAC | DrugsGivenReaction | CC BY | 34056105 | 19,429,833 | 2021-04 |
What was the administration route of drug 'DICLOFENAC'? | Nicolau Syndrome: An Unforeseen Yet Evadable Consequence of Intramuscular Injection.
An intramuscular (IM) injection is one of the common routes for administering drugs, commonly analgesics and vaccines. Nicolau syndrome refers to the rapid-onset painful, extensive cutaneous discoloration progressing to necrosis and ul... | Intramuscular | DrugAdministrationRoute | CC BY | 34056105 | 19,426,438 | 2021-04 |
What was the outcome of reaction 'Acinetobacter infection'? | Nicolau Syndrome: An Unforeseen Yet Evadable Consequence of Intramuscular Injection.
An intramuscular (IM) injection is one of the common routes for administering drugs, commonly analgesics and vaccines. Nicolau syndrome refers to the rapid-onset painful, extensive cutaneous discoloration progressing to necrosis and ul... | Recovered | ReactionOutcome | CC BY | 34056105 | 19,429,833 | 2021-04 |
What was the outcome of reaction 'Blister'? | Nicolau Syndrome: An Unforeseen Yet Evadable Consequence of Intramuscular Injection.
An intramuscular (IM) injection is one of the common routes for administering drugs, commonly analgesics and vaccines. Nicolau syndrome refers to the rapid-onset painful, extensive cutaneous discoloration progressing to necrosis and ul... | Recovered | ReactionOutcome | CC BY | 34056105 | 19,429,833 | 2021-04 |
What was the outcome of reaction 'Embolia cutis medicamentosa'? | Nicolau Syndrome: An Unforeseen Yet Evadable Consequence of Intramuscular Injection.
An intramuscular (IM) injection is one of the common routes for administering drugs, commonly analgesics and vaccines. Nicolau syndrome refers to the rapid-onset painful, extensive cutaneous discoloration progressing to necrosis and ul... | Recovered | ReactionOutcome | CC BY | 34056105 | 19,426,438 | 2021-04 |
What was the outcome of reaction 'Erythema'? | Nicolau Syndrome: An Unforeseen Yet Evadable Consequence of Intramuscular Injection.
An intramuscular (IM) injection is one of the common routes for administering drugs, commonly analgesics and vaccines. Nicolau syndrome refers to the rapid-onset painful, extensive cutaneous discoloration progressing to necrosis and ul... | Recovered | ReactionOutcome | CC BY | 34056105 | 19,429,833 | 2021-04 |
What was the outcome of reaction 'Eschar'? | Nicolau Syndrome: An Unforeseen Yet Evadable Consequence of Intramuscular Injection.
An intramuscular (IM) injection is one of the common routes for administering drugs, commonly analgesics and vaccines. Nicolau syndrome refers to the rapid-onset painful, extensive cutaneous discoloration progressing to necrosis and ul... | Recovered | ReactionOutcome | CC BY | 34056105 | 19,429,833 | 2021-04 |
What was the outcome of reaction 'Klebsiella infection'? | Nicolau Syndrome: An Unforeseen Yet Evadable Consequence of Intramuscular Injection.
An intramuscular (IM) injection is one of the common routes for administering drugs, commonly analgesics and vaccines. Nicolau syndrome refers to the rapid-onset painful, extensive cutaneous discoloration progressing to necrosis and ul... | Recovered | ReactionOutcome | CC BY | 34056105 | 19,429,833 | 2021-04 |
What was the outcome of reaction 'Lymphocytic infiltration'? | Nicolau Syndrome: An Unforeseen Yet Evadable Consequence of Intramuscular Injection.
An intramuscular (IM) injection is one of the common routes for administering drugs, commonly analgesics and vaccines. Nicolau syndrome refers to the rapid-onset painful, extensive cutaneous discoloration progressing to necrosis and ul... | Recovered | ReactionOutcome | CC BY | 34056105 | 19,429,833 | 2021-04 |
What was the outcome of reaction 'Necrosis'? | Nicolau Syndrome: An Unforeseen Yet Evadable Consequence of Intramuscular Injection.
An intramuscular (IM) injection is one of the common routes for administering drugs, commonly analgesics and vaccines. Nicolau syndrome refers to the rapid-onset painful, extensive cutaneous discoloration progressing to necrosis and ul... | Recovered | ReactionOutcome | CC BY | 34056105 | 19,429,833 | 2021-04 |
What was the outcome of reaction 'Neutrophilia'? | Nicolau Syndrome: An Unforeseen Yet Evadable Consequence of Intramuscular Injection.
An intramuscular (IM) injection is one of the common routes for administering drugs, commonly analgesics and vaccines. Nicolau syndrome refers to the rapid-onset painful, extensive cutaneous discoloration progressing to necrosis and ul... | Recovered | ReactionOutcome | CC BY | 34056105 | 19,429,833 | 2021-04 |
What was the outcome of reaction 'Pain'? | Nicolau Syndrome: An Unforeseen Yet Evadable Consequence of Intramuscular Injection.
An intramuscular (IM) injection is one of the common routes for administering drugs, commonly analgesics and vaccines. Nicolau syndrome refers to the rapid-onset painful, extensive cutaneous discoloration progressing to necrosis and ul... | Recovered | ReactionOutcome | CC BY | 34056105 | 19,429,833 | 2021-04 |
What was the outcome of reaction 'Purulent discharge'? | Nicolau Syndrome: An Unforeseen Yet Evadable Consequence of Intramuscular Injection.
An intramuscular (IM) injection is one of the common routes for administering drugs, commonly analgesics and vaccines. Nicolau syndrome refers to the rapid-onset painful, extensive cutaneous discoloration progressing to necrosis and ul... | Recovered | ReactionOutcome | CC BY | 34056105 | 19,429,833 | 2021-04 |
What was the outcome of reaction 'Red blood cell sedimentation rate increased'? | Nicolau Syndrome: An Unforeseen Yet Evadable Consequence of Intramuscular Injection.
An intramuscular (IM) injection is one of the common routes for administering drugs, commonly analgesics and vaccines. Nicolau syndrome refers to the rapid-onset painful, extensive cutaneous discoloration progressing to necrosis and ul... | Recovered | ReactionOutcome | CC BY | 34056105 | 19,429,833 | 2021-04 |
What was the outcome of reaction 'Skin burning sensation'? | Nicolau Syndrome: An Unforeseen Yet Evadable Consequence of Intramuscular Injection.
An intramuscular (IM) injection is one of the common routes for administering drugs, commonly analgesics and vaccines. Nicolau syndrome refers to the rapid-onset painful, extensive cutaneous discoloration progressing to necrosis and ul... | Recovered | ReactionOutcome | CC BY | 34056105 | 19,429,833 | 2021-04 |
What was the outcome of reaction 'Skin discolouration'? | Nicolau Syndrome: An Unforeseen Yet Evadable Consequence of Intramuscular Injection.
An intramuscular (IM) injection is one of the common routes for administering drugs, commonly analgesics and vaccines. Nicolau syndrome refers to the rapid-onset painful, extensive cutaneous discoloration progressing to necrosis and ul... | Recovered | ReactionOutcome | CC BY | 34056105 | 19,429,833 | 2021-04 |
What was the outcome of reaction 'White blood cell count increased'? | Nicolau Syndrome: An Unforeseen Yet Evadable Consequence of Intramuscular Injection.
An intramuscular (IM) injection is one of the common routes for administering drugs, commonly analgesics and vaccines. Nicolau syndrome refers to the rapid-onset painful, extensive cutaneous discoloration progressing to necrosis and ul... | Recovered | ReactionOutcome | CC BY | 34056105 | 19,429,833 | 2021-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | A case report on a rare cause of bowel ischaemia in penetrating trauma.
Gastric mucormycosis is a rare condition that usually manifests in immunocompromised patients. It's a lethal disease with a poor prognosis requiring prompt diagnosis and aggressive management. Although found more commonly in immunocompromised patie... | AMPHOTERICIN B, FLUCONAZOLE | DrugsGivenReaction | CC BY | 34058460 | 19,998,372 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Disease progression'. | Sarcomatoid urothelial carcinoma arising in the female urethral diverticulum.
A sarcomatoid variant of urothelial carcinoma in the female urethral diverticulum has not been reported previously. A 66-year-old woman suffering from dysuria presented with a huge urethral mass invading the urinary bladder and vagina. Histop... | ATEZOLIZUMAB, CISPLATIN, DOXORUBICIN HYDROCHLORIDE, GEMCITABINE, PACLITAXEL | DrugsGivenReaction | CC BY-NC | 34058799 | 20,129,381 | 2021-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Acute myocardial infarction'. | Pancreatic ductal adenocarcinoma concomitant with pancreatic metastases of clear-cell renal cell carcinoma: a case report.
BACKGROUND
Metastatic spread to the pancreas is a rare event. Renal cell carcinoma represents one possible site of origin of pancreatic metastases. Renal cell carcinoma often metastasizes late and ... | FLUOROURACIL, FOLIC ACID, IRINOTECAN, OXALIPLATIN | DrugsGivenReaction | CC BY | 34059139 | 19,461,108 | 2021-05-31 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Pancreatic ductal adenocarcinoma concomitant with pancreatic metastases of clear-cell renal cell carcinoma: a case report.
BACKGROUND
Metastatic spread to the pancreas is a rare event. Renal cell carcinoma represents one possible site of origin of pancreatic metastases. Renal cell carcinoma often metastasizes late and ... | FLUOROURACIL, FOLIC ACID, IRINOTECAN, OXALIPLATIN | DrugsGivenReaction | CC BY | 34059139 | 19,439,402 | 2021-05-31 |
What was the dosage of drug 'FLUOROURACIL'? | Pancreatic ductal adenocarcinoma concomitant with pancreatic metastases of clear-cell renal cell carcinoma: a case report.
BACKGROUND
Metastatic spread to the pancreas is a rare event. Renal cell carcinoma represents one possible site of origin of pancreatic metastases. Renal cell carcinoma often metastasizes late and ... | UNKNOWN | DrugDosageText | CC BY | 34059139 | 19,461,108 | 2021-05-31 |
What was the dosage of drug 'FOLIC ACID'? | Pancreatic ductal adenocarcinoma concomitant with pancreatic metastases of clear-cell renal cell carcinoma: a case report.
BACKGROUND
Metastatic spread to the pancreas is a rare event. Renal cell carcinoma represents one possible site of origin of pancreatic metastases. Renal cell carcinoma often metastasizes late and ... | UNKNOWN | DrugDosageText | CC BY | 34059139 | 19,461,108 | 2021-05-31 |
What was the dosage of drug 'IRINOTECAN'? | Pancreatic ductal adenocarcinoma concomitant with pancreatic metastases of clear-cell renal cell carcinoma: a case report.
BACKGROUND
Metastatic spread to the pancreas is a rare event. Renal cell carcinoma represents one possible site of origin of pancreatic metastases. Renal cell carcinoma often metastasizes late and ... | UNKNOWN | DrugDosageText | CC BY | 34059139 | 19,461,108 | 2021-05-31 |
What was the dosage of drug 'OXALIPLATIN'? | Pancreatic ductal adenocarcinoma concomitant with pancreatic metastases of clear-cell renal cell carcinoma: a case report.
BACKGROUND
Metastatic spread to the pancreas is a rare event. Renal cell carcinoma represents one possible site of origin of pancreatic metastases. Renal cell carcinoma often metastasizes late and ... | UNKNOWN | DrugDosageText | CC BY | 34059139 | 19,461,108 | 2021-05-31 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Tumour excision'. | Giant Cell Tumor of Bone of the First Rib Successfully Treated with Combined Preoperative Denosumab Therapy and Surgery via a Transmanubrial Approach.
BACKGROUND Giant cell tumor of bone (GCTB) is a locally aggressive, intermediate tumor that rarely metastasizes. GCTB typically affects the ends of long bones and rarely... | DENOSUMAB | DrugsGivenReaction | CC BY-NC-ND | 34059614 | 19,456,509 | 2021-06-01 |
What was the administration route of drug 'DENOSUMAB'? | Giant Cell Tumor of Bone of the First Rib Successfully Treated with Combined Preoperative Denosumab Therapy and Surgery via a Transmanubrial Approach.
BACKGROUND Giant cell tumor of bone (GCTB) is a locally aggressive, intermediate tumor that rarely metastasizes. GCTB typically affects the ends of long bones and rarely... | Subcutaneous | DrugAdministrationRoute | CC BY-NC-ND | 34059614 | 19,456,509 | 2021-06-01 |
What was the outcome of reaction 'Tumour excision'? | Giant Cell Tumor of Bone of the First Rib Successfully Treated with Combined Preoperative Denosumab Therapy and Surgery via a Transmanubrial Approach.
BACKGROUND Giant cell tumor of bone (GCTB) is a locally aggressive, intermediate tumor that rarely metastasizes. GCTB typically affects the ends of long bones and rarely... | Recovering | ReactionOutcome | CC BY-NC-ND | 34059614 | 19,456,509 | 2021-06-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Aggression'. | Brivaracetam Retention Rate and Seizure Outcomes in Patients with Drug-Resistant Focal Epilepsy Included in the Medical Need Program in Belgium: A Real-World, Multicenter, Chart Review.
BACKGROUND
New treatments are needed for patients with drug-resistant epilepsy to improve seizure control without decreasing quality o... | BRIVARACETAM | DrugsGivenReaction | CC BY-NC | 34060026 | 19,450,870 | 2021-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Decreased activity'. | Brivaracetam Retention Rate and Seizure Outcomes in Patients with Drug-Resistant Focal Epilepsy Included in the Medical Need Program in Belgium: A Real-World, Multicenter, Chart Review.
BACKGROUND
New treatments are needed for patients with drug-resistant epilepsy to improve seizure control without decreasing quality o... | BRIVARACETAM | DrugsGivenReaction | CC BY-NC | 34060026 | 19,450,870 | 2021-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Decreased appetite'. | Brivaracetam Retention Rate and Seizure Outcomes in Patients with Drug-Resistant Focal Epilepsy Included in the Medical Need Program in Belgium: A Real-World, Multicenter, Chart Review.
BACKGROUND
New treatments are needed for patients with drug-resistant epilepsy to improve seizure control without decreasing quality o... | BRIVARACETAM | DrugsGivenReaction | CC BY-NC | 34060026 | 19,450,870 | 2021-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Depression'. | Brivaracetam Retention Rate and Seizure Outcomes in Patients with Drug-Resistant Focal Epilepsy Included in the Medical Need Program in Belgium: A Real-World, Multicenter, Chart Review.
BACKGROUND
New treatments are needed for patients with drug-resistant epilepsy to improve seizure control without decreasing quality o... | BRIVARACETAM | DrugsGivenReaction | CC BY-NC | 34060026 | 19,450,870 | 2021-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Dizziness'. | Brivaracetam Retention Rate and Seizure Outcomes in Patients with Drug-Resistant Focal Epilepsy Included in the Medical Need Program in Belgium: A Real-World, Multicenter, Chart Review.
BACKGROUND
New treatments are needed for patients with drug-resistant epilepsy to improve seizure control without decreasing quality o... | BRIVARACETAM | DrugsGivenReaction | CC BY-NC | 34060026 | 19,450,870 | 2021-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Headache'. | Brivaracetam Retention Rate and Seizure Outcomes in Patients with Drug-Resistant Focal Epilepsy Included in the Medical Need Program in Belgium: A Real-World, Multicenter, Chart Review.
BACKGROUND
New treatments are needed for patients with drug-resistant epilepsy to improve seizure control without decreasing quality o... | BRIVARACETAM | DrugsGivenReaction | CC BY-NC | 34060026 | 19,450,870 | 2021-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Nausea'. | Brivaracetam Retention Rate and Seizure Outcomes in Patients with Drug-Resistant Focal Epilepsy Included in the Medical Need Program in Belgium: A Real-World, Multicenter, Chart Review.
BACKGROUND
New treatments are needed for patients with drug-resistant epilepsy to improve seizure control without decreasing quality o... | BRIVARACETAM | DrugsGivenReaction | CC BY-NC | 34060026 | 19,450,870 | 2021-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Suicidal ideation'. | Brivaracetam Retention Rate and Seizure Outcomes in Patients with Drug-Resistant Focal Epilepsy Included in the Medical Need Program in Belgium: A Real-World, Multicenter, Chart Review.
BACKGROUND
New treatments are needed for patients with drug-resistant epilepsy to improve seizure control without decreasing quality o... | BRIVARACETAM | DrugsGivenReaction | CC BY-NC | 34060026 | 19,450,870 | 2021-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Thrombocytopenia'. | Brivaracetam Retention Rate and Seizure Outcomes in Patients with Drug-Resistant Focal Epilepsy Included in the Medical Need Program in Belgium: A Real-World, Multicenter, Chart Review.
BACKGROUND
New treatments are needed for patients with drug-resistant epilepsy to improve seizure control without decreasing quality o... | BRIVARACETAM | DrugsGivenReaction | CC BY-NC | 34060026 | 19,450,870 | 2021-09 |
What was the dosage of drug 'BRIVARACETAM'? | Brivaracetam Retention Rate and Seizure Outcomes in Patients with Drug-Resistant Focal Epilepsy Included in the Medical Need Program in Belgium: A Real-World, Multicenter, Chart Review.
BACKGROUND
New treatments are needed for patients with drug-resistant epilepsy to improve seizure control without decreasing quality o... | UNKNOWN DOSE | DrugDosageText | CC BY-NC | 34060026 | 19,451,067 | 2021-09 |
What was the dosage of drug 'LEVETIRACETAM'? | Brivaracetam Retention Rate and Seizure Outcomes in Patients with Drug-Resistant Focal Epilepsy Included in the Medical Need Program in Belgium: A Real-World, Multicenter, Chart Review.
BACKGROUND
New treatments are needed for patients with drug-resistant epilepsy to improve seizure control without decreasing quality o... | UNKNOWN DOSE | DrugDosageText | CC BY-NC | 34060026 | 19,451,067 | 2021-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Treatment failure'. | Characterization of Differentially Detectable Mycobacterium tuberculosis in the Sputum of Subjects with Drug-Sensitive or Drug-Resistant Tuberculosis before and after Two Months of Therapy.
Standard methods for enumerating Mycobacterium tuberculosis in patient sputum can miss large populations of viable M. tuberculosis... | ETHAMBUTOL HYDROCHLORIDE, ISONIAZID, PYRAZINAMIDE, RIFAMPIN | DrugsGivenReaction | CC BY | 34060896 | 20,179,856 | 2021-07-16 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Myelosuppression'. | Lung squamous cell carcinoma with severe hypomagnesemia due to cisplatin plus gemcitabine in combination with necitumumab therapy: A case report.
A 72-year-old man, diagnosed with advanced lung squamous cell carcinoma, was administered of cisplatin plus gemcitabine with necitumumab, a human monoclonal antibody that bin... | ASPIRIN, ATORVASTATIN, CISPLATIN, GEMCITABINE HYDROCHLORIDE, LOSARTAN, NECITUMUMAB, TILIDINE | DrugsGivenReaction | CC BY-NC-ND | 34061460 | 19,481,297 | 2021-07 |
What was the administration route of drug 'CISPLATIN'? | Lung squamous cell carcinoma with severe hypomagnesemia due to cisplatin plus gemcitabine in combination with necitumumab therapy: A case report.
A 72-year-old man, diagnosed with advanced lung squamous cell carcinoma, was administered of cisplatin plus gemcitabine with necitumumab, a human monoclonal antibody that bin... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC-ND | 34061460 | 19,481,297 | 2021-07 |
What was the administration route of drug 'GEMCITABINE HYDROCHLORIDE'? | Lung squamous cell carcinoma with severe hypomagnesemia due to cisplatin plus gemcitabine in combination with necitumumab therapy: A case report.
A 72-year-old man, diagnosed with advanced lung squamous cell carcinoma, was administered of cisplatin plus gemcitabine with necitumumab, a human monoclonal antibody that bin... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC-ND | 34061460 | 19,481,297 | 2021-07 |
What was the administration route of drug 'NECITUMUMAB'? | Lung squamous cell carcinoma with severe hypomagnesemia due to cisplatin plus gemcitabine in combination with necitumumab therapy: A case report.
A 72-year-old man, diagnosed with advanced lung squamous cell carcinoma, was administered of cisplatin plus gemcitabine with necitumumab, a human monoclonal antibody that bin... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC-ND | 34061460 | 19,481,297 | 2021-07 |
What was the dosage of drug 'GEMCITABINE HYDROCHLORIDE'? | Lung squamous cell carcinoma with severe hypomagnesemia due to cisplatin plus gemcitabine in combination with necitumumab therapy: A case report.
A 72-year-old man, diagnosed with advanced lung squamous cell carcinoma, was administered of cisplatin plus gemcitabine with necitumumab, a human monoclonal antibody that bin... | UNSPECIFIED DOSE, EVERY 3 WEEKS, ON DAYS 1 AND 8 | DrugDosageText | CC BY-NC-ND | 34061460 | 19,481,297 | 2021-07 |
What was the dosage of drug 'GEMCITABINE'? | Lung squamous cell carcinoma with severe hypomagnesemia due to cisplatin plus gemcitabine in combination with necitumumab therapy: A case report.
A 72-year-old man, diagnosed with advanced lung squamous cell carcinoma, was administered of cisplatin plus gemcitabine with necitumumab, a human monoclonal antibody that bin... | EVERY 3 WEEKS ON DAYS 1 AND 8 | DrugDosageText | CC BY-NC-ND | 34061460 | 19,477,097 | 2021-07 |
What was the outcome of reaction 'Diarrhoea'? | Lung squamous cell carcinoma with severe hypomagnesemia due to cisplatin plus gemcitabine in combination with necitumumab therapy: A case report.
A 72-year-old man, diagnosed with advanced lung squamous cell carcinoma, was administered of cisplatin plus gemcitabine with necitumumab, a human monoclonal antibody that bin... | Recovered | ReactionOutcome | CC BY-NC-ND | 34061460 | 19,477,097 | 2021-07 |
What was the outcome of reaction 'Hypocalcaemia'? | Lung squamous cell carcinoma with severe hypomagnesemia due to cisplatin plus gemcitabine in combination with necitumumab therapy: A case report.
A 72-year-old man, diagnosed with advanced lung squamous cell carcinoma, was administered of cisplatin plus gemcitabine with necitumumab, a human monoclonal antibody that bin... | Recovered | ReactionOutcome | CC BY-NC-ND | 34061460 | 19,477,097 | 2021-07 |
What was the outcome of reaction 'Hypokalaemia'? | Lung squamous cell carcinoma with severe hypomagnesemia due to cisplatin plus gemcitabine in combination with necitumumab therapy: A case report.
A 72-year-old man, diagnosed with advanced lung squamous cell carcinoma, was administered of cisplatin plus gemcitabine with necitumumab, a human monoclonal antibody that bin... | Recovered | ReactionOutcome | CC BY-NC-ND | 34061460 | 19,477,097 | 2021-07 |
What was the outcome of reaction 'Hypomagnesaemia'? | Lung squamous cell carcinoma with severe hypomagnesemia due to cisplatin plus gemcitabine in combination with necitumumab therapy: A case report.
A 72-year-old man, diagnosed with advanced lung squamous cell carcinoma, was administered of cisplatin plus gemcitabine with necitumumab, a human monoclonal antibody that bin... | Recovered | ReactionOutcome | CC BY-NC-ND | 34061460 | 19,477,097 | 2021-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Exposure during pregnancy'. | Fertility, Pregnancy and Lactation Considerations for Women with CF in the CFTR Modulator Era.
Cystic fibrosis (CF) is an autosomal recessive genetic disorder impacting approximately 80,000 people of all races and ethnicities world-wide. CF is caused by mutations in the cystic fibrosis transmembrane conductance regulat... | ELEXACAFTOR\IVACAFTOR\TEZACAFTOR | DrugsGivenReaction | CC BY | 34063507 | 19,640,242 | 2021-05-15 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Shoulder dystocia'. | Fertility, Pregnancy and Lactation Considerations for Women with CF in the CFTR Modulator Era.
Cystic fibrosis (CF) is an autosomal recessive genetic disorder impacting approximately 80,000 people of all races and ethnicities world-wide. CF is caused by mutations in the cystic fibrosis transmembrane conductance regulat... | ELEXACAFTOR\IVACAFTOR\TEZACAFTOR | DrugsGivenReaction | CC BY | 34063507 | 19,640,242 | 2021-05-15 |
What is the weight of the patient? | Fertility, Pregnancy and Lactation Considerations for Women with CF in the CFTR Modulator Era.
Cystic fibrosis (CF) is an autosomal recessive genetic disorder impacting approximately 80,000 people of all races and ethnicities world-wide. CF is caused by mutations in the cystic fibrosis transmembrane conductance regulat... | 61 kg. | Weight | CC BY | 34063507 | 19,640,242 | 2021-05-15 |
What was the administration route of drug 'ELEXACAFTOR\IVACAFTOR\TEZACAFTOR'? | Fertility, Pregnancy and Lactation Considerations for Women with CF in the CFTR Modulator Era.
Cystic fibrosis (CF) is an autosomal recessive genetic disorder impacting approximately 80,000 people of all races and ethnicities world-wide. CF is caused by mutations in the cystic fibrosis transmembrane conductance regulat... | Oral | DrugAdministrationRoute | CC BY | 34063507 | 19,640,242 | 2021-05-15 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cerebrovascular accident'. | Real-World Experience with Targeted Therapy in BRAF Mutant Advanced Melanoma Patients: Results from a Multicenter Retrospective Observational Study Advanced Melanoma in Russia (Experience) (ADMIRE).
Clinical trials of targeted therapy (TT) and immunotherapy (IT) for highly aggressive advanced melanoma have shown marked... | COBIMETINIB, DABRAFENIB, TRAMETINIB, VEMURAFENIB | DrugsGivenReaction | CC BY | 34064013 | 19,414,751 | 2021-05-21 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Dry skin'. | Real-World Experience with Targeted Therapy in BRAF Mutant Advanced Melanoma Patients: Results from a Multicenter Retrospective Observational Study Advanced Melanoma in Russia (Experience) (ADMIRE).
Clinical trials of targeted therapy (TT) and immunotherapy (IT) for highly aggressive advanced melanoma have shown marked... | COBIMETINIB, DABRAFENIB, TRAMETINIB, VEMURAFENIB | DrugsGivenReaction | CC BY | 34064013 | 19,414,751 | 2021-05-21 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Fatigue'. | Real-World Experience with Targeted Therapy in BRAF Mutant Advanced Melanoma Patients: Results from a Multicenter Retrospective Observational Study Advanced Melanoma in Russia (Experience) (ADMIRE).
Clinical trials of targeted therapy (TT) and immunotherapy (IT) for highly aggressive advanced melanoma have shown marked... | COBIMETINIB, DABRAFENIB, TRAMETINIB, VEMURAFENIB | DrugsGivenReaction | CC BY | 34064013 | 19,414,751 | 2021-05-21 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pyrexia'. | Real-World Experience with Targeted Therapy in BRAF Mutant Advanced Melanoma Patients: Results from a Multicenter Retrospective Observational Study Advanced Melanoma in Russia (Experience) (ADMIRE).
Clinical trials of targeted therapy (TT) and immunotherapy (IT) for highly aggressive advanced melanoma have shown marked... | COBIMETINIB, DABRAFENIB, TRAMETINIB, VEMURAFENIB | DrugsGivenReaction | CC BY | 34064013 | 19,414,751 | 2021-05-21 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Rash'. | Real-World Experience with Targeted Therapy in BRAF Mutant Advanced Melanoma Patients: Results from a Multicenter Retrospective Observational Study Advanced Melanoma in Russia (Experience) (ADMIRE).
Clinical trials of targeted therapy (TT) and immunotherapy (IT) for highly aggressive advanced melanoma have shown marked... | COBIMETINIB, DABRAFENIB, TRAMETINIB, VEMURAFENIB | DrugsGivenReaction | CC BY | 34064013 | 19,414,751 | 2021-05-21 |
What was the outcome of reaction 'Cerebrovascular accident'? | Real-World Experience with Targeted Therapy in BRAF Mutant Advanced Melanoma Patients: Results from a Multicenter Retrospective Observational Study Advanced Melanoma in Russia (Experience) (ADMIRE).
Clinical trials of targeted therapy (TT) and immunotherapy (IT) for highly aggressive advanced melanoma have shown marked... | Fatal | ReactionOutcome | CC BY | 34064013 | 19,414,751 | 2021-05-21 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Disease progression'. | Two Cases of Pancytopenia with Coombs-Negative Hemolytic Anemia after Chimeric Antigen Receptor T-Cell Therapy.
BACKGROUND
Chimeric antigen receptor (CAR) T-cells are changing the therapeutic landscape of hematologic malignancies. Severe side effects include cytokine release syndrome (CRS) and immune effector cell-asso... | BENDAMUSTINE, CISPLATIN, CYCLOPHOSPHAMIDE, DEXAMETHASONE, FLUDARABINE PHOSPHATE, GEMCITABINE, RITUXIMAB | DrugsGivenReaction | CC BY | 34064196 | 19,972,525 | 2021-05-21 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | Two Cases of Pancytopenia with Coombs-Negative Hemolytic Anemia after Chimeric Antigen Receptor T-Cell Therapy.
BACKGROUND
Chimeric antigen receptor (CAR) T-cells are changing the therapeutic landscape of hematologic malignancies. Severe side effects include cytokine release syndrome (CRS) and immune effector cell-asso... | BREXUCABTAGENE AUTOLEUCEL, CYCLOPHOSPHAMIDE, DOXORUBICIN, PREDNISONE, RITUXIMAB, VINCRISTINE | DrugsGivenReaction | CC BY | 34064196 | 20,333,776 | 2021-05-21 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Neurotoxicity'. | Two Cases of Pancytopenia with Coombs-Negative Hemolytic Anemia after Chimeric Antigen Receptor T-Cell Therapy.
BACKGROUND
Chimeric antigen receptor (CAR) T-cells are changing the therapeutic landscape of hematologic malignancies. Severe side effects include cytokine release syndrome (CRS) and immune effector cell-asso... | BREXUCABTAGENE AUTOLEUCEL, CYCLOPHOSPHAMIDE, DOXORUBICIN, PREDNISONE, RITUXIMAB, VINCRISTINE | DrugsGivenReaction | CC BY | 34064196 | 20,333,776 | 2021-05-21 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Therapy partial responder'. | Two Cases of Pancytopenia with Coombs-Negative Hemolytic Anemia after Chimeric Antigen Receptor T-Cell Therapy.
BACKGROUND
Chimeric antigen receptor (CAR) T-cells are changing the therapeutic landscape of hematologic malignancies. Severe side effects include cytokine release syndrome (CRS) and immune effector cell-asso... | BENDAMUSTINE, CISPLATIN, CYCLOPHOSPHAMIDE, DEXAMETHASONE, DOXORUBICIN, FLUDARABINE PHOSPHATE, GEMCITABINE, POLATUZUMAB VEDOTIN, PREDNISONE, RITUXIMAB, TISAGENLECLEUCEL, VINCRISTINE | DrugsGivenReaction | CC BY | 34064196 | 20,319,607 | 2021-05-21 |
What was the administration route of drug 'TISAGENLECLEUCEL'? | Two Cases of Pancytopenia with Coombs-Negative Hemolytic Anemia after Chimeric Antigen Receptor T-Cell Therapy.
BACKGROUND
Chimeric antigen receptor (CAR) T-cells are changing the therapeutic landscape of hematologic malignancies. Severe side effects include cytokine release syndrome (CRS) and immune effector cell-asso... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34064196 | 20,297,775 | 2021-05-21 |
What was the dosage of drug 'CYCLOPHOSPHAMIDE'? | Two Cases of Pancytopenia with Coombs-Negative Hemolytic Anemia after Chimeric Antigen Receptor T-Cell Therapy.
BACKGROUND
Chimeric antigen receptor (CAR) T-cells are changing the therapeutic landscape of hematologic malignancies. Severe side effects include cytokine release syndrome (CRS) and immune effector cell-asso... | R-CHOP REGIMEN | DrugDosageText | CC BY | 34064196 | 20,333,776 | 2021-05-21 |
What was the dosage of drug 'DOXORUBICIN'? | Two Cases of Pancytopenia with Coombs-Negative Hemolytic Anemia after Chimeric Antigen Receptor T-Cell Therapy.
BACKGROUND
Chimeric antigen receptor (CAR) T-cells are changing the therapeutic landscape of hematologic malignancies. Severe side effects include cytokine release syndrome (CRS) and immune effector cell-asso... | R-CHOP REGIMEN | DrugDosageText | CC BY | 34064196 | 20,333,776 | 2021-05-21 |
What was the dosage of drug 'PREDNISONE'? | Two Cases of Pancytopenia with Coombs-Negative Hemolytic Anemia after Chimeric Antigen Receptor T-Cell Therapy.
BACKGROUND
Chimeric antigen receptor (CAR) T-cells are changing the therapeutic landscape of hematologic malignancies. Severe side effects include cytokine release syndrome (CRS) and immune effector cell-asso... | R-CHOP REGIMEN | DrugDosageText | CC BY | 34064196 | 20,333,776 | 2021-05-21 |
What was the dosage of drug 'RITUXIMAB'? | Two Cases of Pancytopenia with Coombs-Negative Hemolytic Anemia after Chimeric Antigen Receptor T-Cell Therapy.
BACKGROUND
Chimeric antigen receptor (CAR) T-cells are changing the therapeutic landscape of hematologic malignancies. Severe side effects include cytokine release syndrome (CRS) and immune effector cell-asso... | R-CHOP REGIMEN | DrugDosageText | CC BY | 34064196 | 20,333,776 | 2021-05-21 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.